Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Melanoma 1Lung Neoplasms 1Liver Neoplasms 1Gestational Trophoblastic Disease 1Esophageal Squamous Cell Carcinoma 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Early Intervention, Educational 29Educational Status 28Blood Specimen Collection 28Standard of Care 26Methods 24Exercise 20Magnetic Resonance Spectroscopy 19Radiosurgery 18Surveys and Questionnaires 17Practice Guidelines as Topic 17X-Rays 16Tomography, X-Ray Computed 13Radiotherapy 11Biopsy 11Specimen Handling 10Interviews as Topic 10Fluorodeoxyglucose F18 10Patient Navigation 9Bronchoscopy 9Thoracic Surgery, Video-Assisted 8Therapeutics 8Saline Solution 7Psychiatric Rehabilitation 7Palliative Care 7Control Groups 7Acupuncture Therapy 7Drug Therapy 6Cryosurgery 6Counseling 6Breathing Exercises 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lung Neoplasms × toripalimab × Clear all
NCT04731909 2021-02-10

Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer

Third Military Medical University

Phase NA Unknown
80 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡